Metropolis Healthcare Limited

Metropolis Healthcare Limited is one of India's leading diagnostics companies, offering a wide spectrum of clinical laboratory tests and profiles used for disease prediction, prevention, detection, and management. Its service test menu comprises over 4,000 routine and specialized pathology tests, ranging from basic blood examinations to advanced molecular diagnostics, oncology testing, and cytogenetics. Founded in 1981 by Dr. Sushil Kanubhai Shah, the business originated as a single clinical laboratory in Mumbai and expanded under the leadership of Managing Director Ameera Sushil Shah. The company operates an extensive hub-and-spoke operational network comprising a central global reference laboratory in Mumbai, regional reference laboratories, clinical laboratories, and thousands of patient service centers across India, Africa, South Asia, and the Middle East. Metropolis Healthcare holds quality accreditations from international and domestic regulatory bodies, including the College of American Pathologists (CAP) and the National Accreditation Board for Testing and Calibration Laboratories (NABL). The business focuses on automated laboratory processes, digital test reporting, and expanding consumer-facing wellness and home sample collection services.

Metropolis Healthcare Limited allocated 60,23,293 equity shares to 26 anchor investors at Rs 880 per share, raising Rs 530.05 crore. Key anchor investors included Small Cap World Fund, Fundsmith Emerging Equities Trust, CDPQ, Sundaram Mutual Fund, UTI Equity Fund, Edelweiss Crossover Opportunities Fund, and Neuberger Berman.